$11.00
+ $0.04 (0.36%)
End-of-day quote: 05/24/2024
NasdaqCM:INO
Add to Portfolio

Inovio Pharmaceuticals Annual Report

Year Year 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004
Rev. Revenue
$0.83M $10.26M $1.77M $7.41M $4.11M $30.48M $42.22M $35.37M $40.57M $10.46M $13.47M $4.12M $9.80M $6.14M $9.12M $2.10M $4.81M $3.47M $5.47M $1.17M
GM % Gross Margin %
100.00% 0.00% 0.00% 100.00% 0.00% -212.51% -133.47% -150.82% -42.44% -226.06% -58.67% 0.00% -104.51% -105.86% 3.41% -154.02% -90.03% -131.27% -99.40% 0.00%
OM Operating Margin
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -200.48% -218.38% -86.97% 0.00% -159.97% 0.00% -226.90% 0.00% -153.04% 0.00% 0.00% 0.00% -222.69% 0.00%
EPS Earnings Per Share
$0.00 $-6.09 $-1.17 $-1.45 $-0.83 $-1.21 $-1.05 $-1.08 $-1.01 $-0.43 $-0.61 $-1.44 $-0.61 $-0.50 $-0.64 $-0.80 $-1.20 $-1.08 $-1.84 $-2.52 $-2.72
Div. Dividends
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio %
-0.00% -0.00% -0.00% 0 0 -0.00% -0.00% 0 0 0 0 0 0 0 0 0 0 0 0 0
Sha. Shares
22.79m 21.09m 217.38m 186.85m 101.36m 97.23m 90.36m 74.06m 72.22m 60.74m 52.58m 36.08m 33.74m 26.26m 25.69m 11.01m 10.95m 8.91m 7.37m 4.61m
OCF Operating Cash Flow
$-124.37M $-216.22M $-215.71M $-177.98M $-97.85M $-73.55M $-63.21M $-62.56M $-12.44M $-29.82M $-15.38M $-22.31M $-19.76M $-11.94M $-14.08M $-11.13M $-11.51M $-7.04M $-12.31M $-6.80M
FCF Free Cash Flow
$-135.00M $-217.18M $-216.94M $-179.50M $-98.84M $-75.64M $-73.50M $-65.30M $-15.22M $-31.20M $-15.56M $-22.55M $-19.92M $-12.12M $-14.13M $-11.25M $-11.65M $-7.09M $-12.60M $-6.90M
FCFS Free Cash Flow Per Share
$-5.62 $-10.92 $-1.04 $-1.16 $-1.00 $-0.82 $-0.89 $-0.89 $-0.21 $-0.53 $-0.29 $-0.64 $-0.62 $-0.47 $-0.76 $-1.07 $-1.17 $-1.08 $-2.87 $-1.71